The 2020 Michelson Prizes will focus on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery.
The selection committee will be looking to support research that is both highly innovative and has the potential for high impact. Specifically, projects should propose innovative ideas and approaches that can be applied across many disease areas and states. Projects should have the potential to significantly expand our understanding of the human immune system and accelerate the development of vaccines and immunotherapies. While the Michelson Prizes are focused on research in the fields of immunology, vaccine and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.
Additional info can be found at https://www.humanvaccinesproject.org/michelsonprizes/